Medscape | Is Obinutuzumab the Drug to Watch in CLL? Medscape Maintenance therapy in follicular lymphoma -- for example, the PRIMA study and the SAKK study, in which different durations of continuous rituximab were applied -- there were some updates of these studies at the current meeting. What did you think of them? |
